(Q35607857)

English

Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure

scientific article published on December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

author name string

Ali Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

709-715

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Mechanism of action of beta-blocking agents in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

beta-adrenergic mechanisms in cardiac diseases: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Perspectives on mammalian cardiovascular aging: humans to molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Phospholamban: a prominent regulator of myocardial contractility

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Cardiac adrenergic receptor effects of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Beta-blockade in heart failure. Basic concepts and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Carvedilol in elderly patients with chronic heart failure, a 12 weeks randomized, placebo controlled open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

21 January 2018

Diminished inotropic response of aged myocardium to catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related changes in beta-adrenergic neuroeffector systems in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

What type of beta-blocker should be used to treat chronic heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the beta blocker bucindolol in younger versus older patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900058-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(03)00058-8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35607857&oldid=2049223150"